» Articles » PMID: 11016927

Non-redundant Signal Transduction of Interleukin-6-type Cytokines. The Adapter Protein Shc is Specifically Recruited to Rhe Oncostatin M Receptor

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2000 Oct 4
PMID 11016927
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The common use of the cytokine receptor gp130 has served as an explanation for the extremely redundant biological activities exerted by interleukin (IL)-6-type cytokines. Indeed, hardly any differences in signal transduction initiated by these cytokines are known. In the present study, we demonstrate that oncostatin M (OSM), but not IL-6 or leukemia inhibitory factor, induces tyrosine phosphorylation of the Shc isoforms p52 and p66 and their association with Grb2. Concomitantly, OSM turns out to be a stronger activator of ERK1/2 MAPKs. Shc is recruited to the OSM receptor (OSMR), but not to gp130. Binding involves Tyr(861) of the OSMR, located within a consensus binding sequence for the Shc PTB domain. Moreover, Tyr(861) is essential for activation of ERK1/2 and for full activation of the alpha(2)-macroglobulin promoter, but not for an exclusively STAT-responsive promoter. This study therefore provides evidence for qualitative differential signaling mechanisms exerted by IL-6-type cytokines.

Citing Articles

Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems.

Sims N, Levesque J Curr Osteoporos Rep. 2024; 22(1):80-95.

PMID: 38198032 PMC: 10912291. DOI: 10.1007/s11914-023-00837-z.


New perspectives in cancer immunotherapy: targeting IL-6 cytokine family.

Soler M, Abaurrea A, Azcoaga P, Araujo A, Caffarel M J Immunother Cancer. 2023; 11(11).

PMID: 37945321 PMC: 10649711. DOI: 10.1136/jitc-2023-007530.


Oncostatin-M and OSM-Receptor Feed-Forward Activation of MAPK Induces Separable Stem-like and Mesenchymal Programs.

Polak K, Tamagno I, Parameswaran N, Smigiel J, Ricky Chan E, Yuan X Mol Cancer Res. 2023; 21(9):975-990.

PMID: 37310811 PMC: 10527478. DOI: 10.1158/1541-7786.MCR-22-0715.


Gp130-Mediated STAT3 Activation Contributes to the Aggressiveness of Pancreatic Cancer through Long Non-Coding RNA Expression.

Sasaki N, Hirano K, Shichi Y, Gomi F, Yoshimura H, Matsushita A Cancers (Basel). 2022; 14(9).

PMID: 35565185 PMC: 9100112. DOI: 10.3390/cancers14092055.


Oncostatin M Induces Lipolysis and Suppresses Insulin Response in 3T3-L1 Adipocytes.

Bailey J, Hang H, Boudreau A, Elks C Int J Mol Sci. 2022; 23(9).

PMID: 35563078 PMC: 9104719. DOI: 10.3390/ijms23094689.